Examinant per Autoria "Peral, Carmen"
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Ceftaroline fosamil for the empiric treatment of hospitalized adults with cSSTI: an economic analysis from the perspective of the Spanish National Health System(Dove Press, 2022) Torres, Antoni; Soriano, Alex; Rivolo, Simone; Remak, Edit; Peral, Carmen; Kantecki, Michal; Ansari, Wajeeha; Charbonneau, Claudie; Hammond, Jennifer; Grau Cerrato, Santiago; Wilcox, Mark
Ítem Accés Obert Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain(Dove Medical Press, 2016) Grau Cerrato, Santiago; Azanza Perea, José Ramon; Ruiz, Isabel; Vallejo, Carlos; Mensa, Josep; Maertens, Johan; Heinz, Werner; Barrueta, Jon Andoni; Peral, Carmen; Mesa, Francisco Jesús; Barrado, Miguel; Charbonneau, Claudie; Rubio-Rodríguez, Darío; Rubio-Terrés, Carlos
Ítem Accés Obert Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients.(Auckland, NZ : Dove Medical Press, 2015) Grau Cerrato, Santiago; Romá, E.; Salavert, M.; Barrueta, Jon Andoni; Peral, Carmen; Rodriguez, I.; Rubio-Rodríguez, Darío; Rubio-Terrés, Carlos
Ítem Accés Obert Economic analysis of ceftaroline fosamil for treating community-acquired pneumonia in Spain(Taylor & Francis, 2020) Torres, Antoni; Bassetti, Matteo; Welte, Tobias; Rivolo, Simone; Remak, Edit; Peral, Carmen; Charbonneau, Claudie; Hammond, Jennifer; Ansari, Wajeeha; Grau Cerrato, Santiago
Ítem Accés Obert The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain(Wiley-VCH Verlag, 2021) Azanza Perea, José Ramon; Grau Cerrato, Santiago; Vázquez, Lourdes; Rebollo, Pablo; Peral, Carmen; López-Ibáñez de Aldecoa, Alejandra; López-Gómez, Vanessa